Share the post "Choksi Laboratories ‘s Q1 Report: Revenue Rises by 21.59% YoY"
Highlights
- The presented financial data is Standalone to provide a comprehensive overview of the company performance.
- Sales over the Year and quarter: The company experienced a substantial growth of 21.59 % in the past year, decrease in net sales/revenue by -3.45 %.
- Income over the Year and quarter: There has been decline in other income over the past year which is -90.2 %, Marginal decrease of -92.19% in other income during this quarter.
- Profit over the Year and quarter: Significant improvement in profitability for Choksi Laboratories Ltd.. Notable increase of 17.6 % in net profit Year to Year, Choksi Laboratories Ltd.’s profitability dropped by -38.36 % Quarter to Quarter.
- EPS over the Year and quarter: EPS increased by 17.65 % Year to Year. EPS decreased by -38.78 % in previous quarter. Analysis needed for shareholder value.
Metrics | Previous Year | Previous Quarter | Current Quarter | Quarter to Quarter Difference | Year to Year Difference |
---|---|---|---|---|---|
Sales | Rs. 8.83 Cr | Rs. 11.12 Cr | Rs. 10.736 Cr | -3.45 % | + 21.59 % |
Expenses | Rs. 6.45 Cr | Rs. 7.64 Cr | Rs. 7.9 Cr | + 3.4 % | + 22.48 % |
Operating Profit | Rs. 2.38 Cr | Rs. 3.48 Cr | Rs. 2.84 Cr | -18.39 % | + 19.33 % |
OPM % | 26.95 % | 31.29 % | 26.45 % | -4.84 % | -0.5 % |
Other Income | Rs. 0.051 Cr | Rs. 0.064 Cr | Rs. 0.005 Cr | -92.19 % | -90.2 % |
Interest | Rs. 0.82 Cr | Rs. 0.77 Cr | Rs. 0.72 Cr | -6.49 % | -12.2 % |
Depreciation | Rs. 1.39 Cr | Rs. 1.49 Cr | Rs. 1.5 Cr | + 0.67 % | + 7.91 % |
Profit before tax | Rs. 0.22 Cr | Rs. 1.28 Cr | Rs. 0.63 Cr | -50.78 % | + 186.36 % |
Tax % | 60.54 % | 46.93 % | 31.54 % | -15.39 % | -29 % |
Net Profit | Rs. 0.36 Cr | Rs. 0.68 Cr | Rs. 0.42 Cr | -38.24 % | + 16.67 % |
EPS in Rs | Rs. 0.51 | Rs. 0.98 | Rs. 0.6 | -38.78 % | + 17.65 % |
Today, we’re looking at Choksi Laboratories Ltd.’s financial performance for the Q1(Jun 2024).Starting with the top line, the company reported a robust year-over-year sales growth of 21.59 %. However, it did see a marginal slip of -3.45 % from the previous quarter. Expenses ticked up slightly by 3.4 % quarter-on-quarter, aligning with the annual rise of 22.48 %. Operating profit, while up 19.33 % compared to last year, faced a quarter-on-quarter dip of -18.39 %, signaling a short-term contraction in margins.
The Operating Profit Margin (OPM) % contradicts this narrative, showing weakness on an annual basis with a decrease of -0.5 %, but a shrinkage of -4.84 % sequentially. Other income fell by -92.19 % compared to the last quarter, despite an annual decline of -90.2 %. Interest expenses dropped significantly by -6.49 % from the previous quarter, yet the year-over-year decrease remains at a moderate -12.2 %. Depreciation costs climbed by 0.67 % quarter-on-quarter, whereas on an annual scale, they saw an increase of 7.91 %. Profit before tax grew annually by 186.36 % but saw a reduction from the preceding quarter by -50.78 %.
Tax expenses as a percentage of profits decreased slightly by -29 % compared to last year, with a more notable quarter-on-quarter decrease of -15.39 %. Net profit rose by 16.67 % year-on-year but witnessed a -38.24 % contraction from the last quarter. And finally, Earnings Per Share (EPS) displayed an annual uptick of 17.65 % but a quarterly fall of -38.78 %. In summary, Choksi Laboratories Ltd.’s annual performance indicates steady growth, although the quarter-on-quarter figures suggest some areas may require strategic attention.
Metrics | Previous Year | Previous Quarter | Current Quarter | Quarter to Quarter Difference | Year to Year Difference |
---|---|---|---|---|---|
Sales | Rs. 8.83 Cr | Rs. 11.12 Cr | Rs. 10.736 Cr | -3.45 % | + 21.59 % |
Expenses | Rs. 6.45 Cr | Rs. 7.64 Cr | Rs. 7.9 Cr | + 3.4 % | + 22.48 % |
Operating Profit | Rs. 2.38 Cr | Rs. 3.48 Cr | Rs. 2.84 Cr | -18.39 % | + 19.33 % |
Net Profit | Rs. 0.36 Cr | Rs. 0.68 Cr | Rs. 0.42 Cr | -38.24 % | + 16.67 % |
EPS in Rs | Rs. 0.51 | Rs. 0.98 | Rs. 0.6 | -38.78 % | + 17.65 % |
In reviewing Choksi Laboratories Ltd.’s 2024(Q1) financial snapshot, key trends emerge, shedding light on the company’s performance.Sales saw a robust 21.59 % year-on-year growth, although there was a slight dip of -3.45 % from the previous quarter. Expenses rose by 22.48 % compared to the previous year, with a 3.4 % increase quarter-on-quarter. Operating Profit surged by 19.33 % annually, and saw a -18.39 % decrease from the last quarter.
Net Profit showed yearly increase of 16.67 %, and experienced a -38.24 % decrease from the previous quarter. Earnings Per Share (EPS) rose by 17.65 % annually, however dipped by -38.78 % compared to the last quarter. In essence, while Choksi Laboratories Ltd. exhibits strong annual growth indicators, short-term fluctuations suggest the need for agile strategies to navigate market dynamics effectively. That’s all for now in the financial sector.